跳至主要内容
临床试验/NCT04336839
NCT04336839Unknown不适用

Vascular Resection During Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms (PanNENs): a Comparative Single Centre Study

Royal Free Hospital NHS Foundation Trust0 个研究点目标入组 40 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
主要终点
Progression-Free Survival

研究概览

简要总结

The limited evidence on the value of portal vein resection in patients with borderline resectable and/or locally advanced PanNENs is an incentive to carry out a retrospective multicentre study amongst centres with specific interest in the management of PanNENs and with experience on vascular reconstruction. Unlike previous studies on pancreatic cancer, it is more difficult to standardise the comparative parameters as the definition of borderline resectable disease has never been published for PanNENs. Similarly, different histological classifications make impossible to collect data exclusively on T3 tumours. Therefore, we aim to compare the short and long-term outcomes (including the impact of the histological depth of vascular invasion on survival) between patients undergoing standard PD and PD with portal vein resection for PanNENs, (regardless of T stage), by collecting and analysing retrospective data in this single centre study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergoing pancreaticoduodenectomy (Whipple's or Pylorus Preserving Pancreaticoduodenectomy) for sporadic PanNENs of the head of the pancreas of any stage (R0 or R1 resections) operated from 1st January 2007 up to 31st December 2016 inclusive.

排除标准

  • Multiple Neuroendocrine Neoplasia (MEN) syndrome or other genetic background
  • Age <18 years old
  • Total pancreatectomy or different operation rather than PD
  • R2 Resections

结局指标

主要结局

Progression-Free Survival

时间窗: total of 2 years retrospective follow up

Time from surgery to disease progression, or death or completion of follow up

次要结局

  • Histology predictive value(total of 2 years retrospective follow up)
  • Morbidity and mortality rate(total of 2 years retrospective follow up)

研究者

发起方
Royal Free Hospital NHS Foundation Trust
申办方类型
Other
责任方
Sponsor

相似试验